TOPIRAMATE-INDUCED VALPROATE TOXICITY
Three children with severe refractory epilepsy who developed typical valproate (VPA) adverse effects after introducing topiramate (TPM) in combination are reported from the University of Mannheim, Germany. Patient 1 was admitted at 16 months with psychomotor retardation and myoclonic seizures, subsequently diagnosed as Lennox-Gastaut syndrome. Initial treatment with carbamazepine (CBZ) and VPA was ineffective and the combination was changed to VPA and TPM. Apathy, loss of appetite, and fever developed after 4 weeks, and liver enzymes and ammonia levels were elevated. Recovery followed within 6 days after withdrawing VPA and TPM. 
